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Abstract
Background: Tuberculosis (TB), caused by Mycobacterium tuberculosis complex (MTBC), is one of the major causes of death
in the world today. Although China has the second largest global case rate of tuberculosis, a systematic study of TB
prevalence in China has not been completed. From 2006 to 2007, the base line surveillance of tuberculosis was carried out
by Ministry of Health, and more than 4000 representative strains were selected from 31 provinces in China.
Methodology/Principal Findings: The aim of the present research was to survey the genotypes of representative
Mycobacterium tuberculosis (M. tuberculosis) strains from China using spacer oligonucleotide typing (spoligotyping), and to
analyze the relationship between genotype and drug resistance for the first time. A total of 4017 clinical isolates were
collected from 2007 to 2008 throughout China. Among those M. tuberculosis isolates, 2500 (62.2%) isolates were Beijing
genotypes. The percentage of Beijing genotypes in northern China was higher than in southern China (76.5% vs. 53.2%).
Additionally, the frequencies of rifampin-resistant, ofloxacin-resistant and multidrug-resistant isolates were significantly
higher in Beijing genotype strains than non-Beijing strains. Furthermore, a novel genotype named ‘‘China Southern
genotype (CS)’’ was only isolated from Fujian and Guangdong provinces. Hence, it is very practical to uncover the reason for
prevalence of the CS type in southern China.
Conclusions/Significance: In conclusion, Beijing family genotypes were still the predominant genotype throughout China,
which exhibited a greater correlation with rifampin-resistance, ofloxacin-resistance and MDR phenotypes than other TB
spoligotypes, and some regions of China showed several unique characters in the distribution of M. tuberculosis genotypes.
Our research represents an important contribution for the TB control and research community, which completes broad
pictures on drug resistance levels and distribution of M. tuberculosis strain types over China.
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Introduction
Tuberculosis (TB), caused by Mycobacterium tuberculosis
complex (MTBC), is one of the major causes of death in the
world today [1,2]. It is estimated that one-third of the world’s
population has been infected by Mycobacterium tuberculosis. The
situation in developing countries is worse. According to the World
Health Organization (WHO), about 95% of the eight million new
cases each year occur in middle- and low-income countries [2]. It
is well-known that China, where 80% of TB patients live in rural
areas [3], has the second largest population of tuberculosis patients
[4]. Tuberculosis is not only a disease harming people’s health, but
also a social-economic issue [3].
Genotyping of M. tuberculosis isolates has significantly improved
knowledge of the epidemiology of tuberculosis (TB) [5]. With the
use of molecular tools, it is possible to detect unsuspected
transmission, to identify false-positive cultures, and to distinguish
between reinfection and relapse [6]. Spacer oligonucleotide typing
(spoligotyping) is a reliable and informative technology for
characterizing the genetic structure of tuberculosis populations,
especially Beijing family genotype strains [7,8]. Using PCR
technology, spoligotyping analyzes genomic polymorphisms in
the short direct repeat (DR) of M. tuberculosis, a genetic marker
consisting of identical 36-bp DRs interspersed with 35- to 41- bp
non-repetitive spacer sequences [8].
Molecular typing of M.tuberculosis strains from several Asian
countries revealed that a specific family of M. tb strains, named the
Beijing genotype, were the dominant pattern [9].The Beijing
family genotype is also common in the countries of the former
Soviet Union [10], but rare in other regions such as Finland and
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responsible for outbreaks of multidrug-resistant TB (MDR-TB),
and some study indicate that Beijing genotype is associated with
drug resistance [7,12]. Although China has the second largest
global case rate of tuberculosis (TB), a systematic study of TB
prevalence in China, especially Beijing family, has not been
completed. Hence, it is meaningful to analyze the situation of
Beijing genotype in tuberculosis isolates.
In China, the base line surveillance of tuberculosis was carried
out by Ministry of Health recently, and representative strains
selected from 31 provinces in China. In this study, we used
spoligotyping to classify the 4017 representative strains mentioned
above. Our aim was to find the prevalent genotype in China,
especially the prevalence of Beijing genotyping. In addition, the
relationship between genotype and drug-resistance was also
analyzed.
Results
Distribution of different genotypes in China
A collection of 4017 representative M. tuberculosis isolates was
analyzed by spoligotyping in this study. Among these clinical
strains, 2500 (62.2%) belonged to the Beijing genotype, while 1515
(37.8%) were non-Beijing family., demonstrating that the Beiijng
family is still the predominant genotype in China. Strains classified
into non-Beijing family included 182 strains from the MANU2
family (4.5%), 30 from the CAS1-DELH1 family (0.7%), 394 from
the T1 family (9.8%), 126 from the T2 family (2.4%), 585 of new
found genotype (9.8%) and 200 other (5.0%). According to
Chinese Administrative Division, the origin of strains was classified
as either northern (1551) or southern (2466) region isolates. The
percentage of Beijing genotype in the two regions were 76.5% and
53.2%, respectively, which is a statistically significant difference
(x
2=219.69, P,0.0001). That is, the Beijing genotype shows
higher prevalence in the north than south. Prevalence of each of
the non-Beijing genotype families was analyzed individually.
Prevalence of MANU family genotypes were 3.6% and 5.1%,
respectively, a statistically significant value (x
2=4.95, P=0.029).
The differences of T1 (4.3% vs. 13.3%, x
2=88.07, P,0.0001),
CAS-DELHI (1.9% vs. 0.0%, x
2=42.98, P,0.0001) and all newly
discovered (novel) genotypes (7.1% vs. 19.3%, x
2=113.34,
P,0.0001) were also extremely significant. T2 genotype occupied
2.3% vs. 3.6%, the difference of which was significant. And there
was no difference between other genotypes overall (4.3% vs. 5.4%,
x
2=2.32, P=0.136) (Table 1).
Predominant spoligotypes in China
Among the 4017 typed isolates, a total of 568 spoligotypes were
identified. Of these, 98 spoligotypes were previously represented as
Shared International Types (STs) according to SpolDB4.0, while
the other 470 were reported for the first time (Table 2). After
clustering with BioNumerics software, 3610 (89.87%) isolates were
classified into 161 groups containing 2 or more strains. The mean
number of isolates per cluster was 22.42. Additionally, 407
(10.13%) strains did not form clusters (Figure 1, Table 2).
Of the 161 clusters, about 75% of all isolates were contained in
10 predominant clusters. Nine of these (ST1, ST53, ST54, ST52,
ST190, ST37, ST334, ST1184 and ST803) could be found in the
SpolDB4.0 database, while the one remaining (spoligotype:
000000000006771) was newly discovered. Among these 10 types,
ST1 and ST190 were members of the Beijing family, representing
2343 (57.05%) and 55 isolates (1.34%), respectively. As the second
most prevalent type, ST53, the member of T1 family, had 238
(5.79%). Besides, the number of ST54 (MANU2 family), ST52 (T2
family), ST37 (T3 family), ST334 (T1 family), ST1184 (U family)
and ST803 (T1 family) were 158 (3.85%), 85 (2.07%), 31 (0.75%),
30 (0.73%), 25 (0.61%) and 19 (0.46%), respectively. The new
found spoligotye (000000000006771) included 22 isolates (0.54%).
Because this novel type was identified in southern China, it was
designated the ‘‘CS’’ (China Southern) type. According to
minimum spanning tree, the new CS type was more similar to
Beijing genotype than other non-Beijing spoligotypes, and was
only found in Fujian and Guangdong provinces, which were both
located in southern coastal area of China (Table 3, Figure 1).
Table 1. Distribution of different family strains in Northern and Southern regions.
Region No.
{ No. (%)
BEIJING MANU2 CAS1-DELHI T1 T2 New found Others
Total 4017 2500(62.2%) 182(4.5%) 30(0.7%) 394(9.8%) 126(3.1%) 585(14.6%) 200(5.0%)
Northern
{ 1551 1187(76.5%) 56(3.6%) 29(1.9%) 66(4.3%) 36(2.3%) 110(7.1%) 67(4.3%)
Southern
1 2461 1313(53.2%)*** 126(5.1%)* 1(0.0%)*** 328(13.3%)*** 90(3.6%)* 475(19.3%)*** 133(5.4%)
{The number of isolates.
{According to Chinese administrative division, the Northern region of China includes provinces as followed: Heilongjiang, Jilin, Liaoning, Inner Mongolia, Hebei, Beijing,
Tianjin, Shandong, Henan, Shanxi, Shaanxi, Ningxia, Gansu, Qinghai and Xinjiang.
1According to Chinese administrative division, the Southern region of China includes provinces as followed: Jiangsu, Anhui, Hunan, Sichuan, Yunnan, Guizhou,
Guangdong, Guangxi, Fujian, Jiangxi, Zhejiang, Hainan, Xizang, Shanghai and Chongqing.
*: P,0.05 (significant);
**: P,0.01 (highly significant);
***: P,0.001 (extremely significant).
doi:10.1371/journal.pone.0032976.t001
Table 2. Numbers and frequencies of isolates clustered by
spoligotyping.
Parameter Value
No. of isolated studied 4017
No. of clusters 161
No. of new found spoligotype 470
Mean no. of isolates per cluster 22.42
No.(%) of clustered isolated 3610 (89.87)
No.(%) of unclustered isolated 407 (10.13)
doi:10.1371/journal.pone.0032976.t002
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Beijing genotype
Of 4017 strains with genotyping results in this study, complete
drug susceptibility profiles were obtained for 3634 isolates. Of the
latter, 2290 (63.0%) were the Beijing genotype, and the other 1344
(37.0%) were non-Beijing genotypes. As shown in Table 4, 744
(20.5%) were INH resistant, 412 (11.3%) were resistant to RIF,
287 (7.9%) were resistant to EMB, 1073 (29.5%) were SM
resistant, 85 were resistant to Kan and 145 were OFLX resistant.
Of these strains, 62 and 27 isolates were designated MDR (9.9%)
and XDR (0.7%), respectively. The DST results comparison
between Beijing family and non-Beijing family showed that the
percentages of RIF resistant (21.7% vs. 18.4%), OFLX resistant
(4.9% vs. 2.4%) and MDR (11.3% vs. 7.4%) in Beijing genotype
were extremely significantly higher than those of non-Beijing
genotype, the chi-square value of which were (x
2=22.10,
P,0.0001), (x
2=14.42, P,0.0001) and 7.4% (x
2=14.83,
P,0.0001), severalty. Similarly, Beijing family provided higher
proportion in INH resistant (21.7% vs. 18.4%, x
2=5.75,
P=0.017) and EMB (8.8% vs. 6.4%, x
2=6.59, P=0.011) resistant
than non-Beijing family. In contrast, the ratio of SM resistant in
non-Beijing genotype (32.4%) was higher than that of Beijing
(27.9%), the difference of which was highly significant (x
2=8.26,
P=0.004). The percentage of Kan resistant was strikingly similar
for both genotypes. Because the number of XDR isolates identified
was small, there was no statistical difference in XDR frequencies
between Beijing and non-Beijing genotypes (Table 4).
Figure 1. Minimum spanning tree generated with spoligotypes of the respective TB strains from all over the China. Each nodal point
represents a particular spoligotype, and the size of nodal point is relative to the number of strains with that spoligotype. The percentage represents
the proportion of each spoligotype. The annotations in the figure were the 10 most frequent spoligotypes.
doi:10.1371/journal.pone.0032976.g001
Table 3. Prevalence of 10 most common Spoligotyping types
annotated in SpolDB4.0.
Spoligotype description
octonary SIT
* SpolDB4 ID
{ No.
{
Prevalence
1
(%)
000000000003771 1 BEIJING 2343 57.05
777777777760771 53 T1 238 5.79
777777777763771 54 MANU2 158 3.85
777777777760731 52 T2 85 2.07
000000000003731 190 BEIJING 55 1.34
777737777760771 37 T3 31 0.75
577777777760771 334 T1 30 0.73
000002000003771 1184 U 25 0.61
000000000006771 NA
" NA
" 22 0.54
777740007760771 803 T1 19 0.46
*SIT from SpolDB4.0.
{Representing spoligotype families annotated in SpolDB4.0.
{Number of strains with the same SIT.
1Prevalence represents the percentage of isolates with a common SIT among all
isolates in this study.
"NA represents the spoligotyping type which is not found in SpoIDB4.0.
doi:10.1371/journal.pone.0032976.t003
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The five most predominant spoligotypes as well as the newly
described CS spoligotype were selected to determine drug
susceptibility profiles. The ST1 type, a member of Beijing family,
was designated as the control, for comparison with other types. As
shown in Table 5, relative to the ST1 profile, ST53 and ST54
presented bigger difference than other types. As the second most
frequent strain, ST53 displayed lower INH (14.0% vs. 21.7%,
x
2=7.55, P=0.006), RIF (6.0% vs. 13.2%, x
2=8.76, P=0.002)
and OFLX (0% vs. 4.6%, x
2=8.22, P=0.001) resistance. The
frequency of MDR isolates with the ST53 genotype was significantly
lower thanthat of ST1 (6.0%vs. 11.2%,x
2=5.24, P=0.020), which
contributed greatly to low drug resistant percentage of non-Beijing
family. On the contrary, the frequency of drug resistance was higher
in ST54 than ST1, and the proportions of EMB (15.9% vs. 8.6%,
x
2=7.58, P=0.010), INH (31.8% vs. 21.7%, x
2=6.88, P=0.011)
and SM (42.9% vs. 27.8%, x
2=13.26, P=0.001) resistant were
significantly higher. Besides, there were no RIF resistant and MDR
isolate in ST52 type, therefore, the ratio of them is lower than those
of ST1 significantly (Table 5).
Discussion
China has one of the highest tuberculosis burdens in the world.
In previous reports, genotyping was performed on some clinical
TB isolates collected from several areas of China, which provided
us the knowledge about the distribution of dominant TB
genotypes. However, due to incomplete representation, these
strains could not reveal prevalence and epidemic trend of
tuberculosis in China. In this study, 4017 strains were enrolled
from the National Drug Resistance Base-Line Surveillance of
Tuberculosis. Of these, 62.2% were representatives of the Beijing
genotype. Early research based on clinical isolates of different
region showed that the percentage of Beijing genotype varied from
67.1% to 92% [7,11,13–17], which was higher than our research.
The explanation of this obvious difference may be that the strains
used in previous study were obtained from clinical hospital instead
of epidemiological survey. In comparison with surrounding
countries, prevalence of the Beijing genotype of this study is less
than Hong Kong (70%) [18], but more than Taiwan (44.4%) [19],
Vietnam (54%) [20], Thailand (44%) [21] and Russia (44.5%)
[22]. Hence, this study demonstrates that the Beijing genotype is a
dominant TB genotype of China.
Table 4. Prevalence of antituberculosis drug resistance among 3634 isolates in China TB survilliance by genotype.
Genotype % Resistance to
{:
Isonazid Rifampin Ethambutol Streptomycin Kanamycin Ofloxacin MDR
{ XDR
1
Beijing (n=2290) 21.7 13.2 8.8 27.9 2.2 4.9 11.3 1.0
Non-Beijing (n=1344) 18.4* 8.1*** 6.4* 32.4** 2.5 2.4*** 7.4*** 0.4
Odds ratio 1.23 1.73 1.41 0.81 0.88 2.13 1.60 2.60
95% CI 1.04–1.46 1.37–2.18 1.08–1.83 0.70–0.93 0.57–1.36 1.43–3.17 1.26–2.04 0.98–6.88
{Isolates resistant to isonazid (n=744; 20.5%), rifampin (n=412; 11.3%), ethambutol (n=287; 7.9%), streptomycin (n=1073; 29.5%), kanamycin (n=85; 2.3%), ofloxacin
(n=145; 4.0%), multiple drugs (MDR) (n=62; 9.9%) or extensively drugs (XDR) (n=27; 0.7%).
{MDR, multidrug resistant, represents isolates resistant to at least isonazid and rifampin.
1XDR, extensively drug resistant, represents isolates resistant to at least rifampicin and isoniazid, as well as any member of the quinolone family and at least one of the
following second-line anti-TB injectable drugs.
*: P,0.05 (significant);
**: P,0.01 (highly significant);
***: P,0.001 (extremely significant).
doi:10.1371/journal.pone.0032976.t004
Table 5. Prevalence of antituberculosis drug resistance among the most popular genotypes in China TB survilliance.
SIT
{ SpolDB4 ID
{ No.
1 % Resistance to :
Isonazid Rifampin Ethambutol Streptomycin Kanamycin Ofloxacin MDR
"
1 BEIJING 2153 21.7 13.2 8.6 27.8 2.0 4.6 11.2
53 T1 212 14.0** 6.0** 5.0* 33.0 2.0 0** 6.0*
54 MANU2 126 31.8** 15.9 15.9** 42.9*** 4.0 4.0 15.1
52 T2 76 21.1 0** 2.6 31.6 0 2.6 0**
190 BEIJING 51 11.8 5.9 5.9 31.4 3.9 0 3.9
New New 20 25.0 15.0 10.0 20.0 0 10.0 15.0
{SIT from SpolDB4.0.
{Representing spoligotype families annotated in SpolDB4.0.
1Number of isolates with both the same SIT and results of drug sensitive test.
"MDR, multidrug resistant, represents isolates resistant to at least isonazid and rifampin.
*: P,0.05 (significant);
**: P,0.01 (highly significant);
***: P,0.001 (extremely significant).
doi:10.1371/journal.pone.0032976.t005
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north and south China showed different characteristics. The main
diversity was that the proportion of Beijing genotype in the north
area was higher than that in the south area. However, the T family
genotype, one of the prevalent genotypes in Africa, Central and
South America and Europe [23], was significantly higher in
southern China than in the north. In addition, more novel
spoligotypes were identified in southern China. Overall, the genetic
variability of the DR locus was more diversified in the south of
China, and several reasons may be responsible for it. First of all, the
economicstateand trafficconditionofsouthernisbetterthanthatof
northern, causing more frequent movement of the population
between either different provinces or different countries in south
area. Additional, the dissimilar customs adapted to the each climate
may the other possible reason for this diversity. People lived in the
north China will share longer indoor time because of cold winter
months, which may be related with the prevalence of Beijing
genotype. However, the proof of this hypothesis is difficult since the
more population-based epidemical results are necessary. Interest-
ingly, CAS1-DEHL1 type was almost exclusively detected in
northern China (29/30). Of the 29 isolates, 26 were collected from
Xinjiang Uygur Autonomous Region. In a previous report, the
Middle East, and Central and Southern Asia were ‘‘high incidence’’
areas of CAS1-DEHL1 family [23–25]. Obviously, the Xinjiang
region is adjacent to several Central Asian countries and they share
similar culture traditions. Hence, frequent movement of ethnic
groups may be the major factor to explain the prevalence of the
CAS1-DEHL1 genotype in Xinjiang [26].
According to subtype analysis with Shared International Types
(SITs), a novel CS genotype containing 22 strains was all
indentified among the isolates from Fujian and Guangdong
provinces, which were all located in the south area of China.
Hence, it is very practical to uncover the reason for prevalence of
the CS type in southern China. In general, as the high prevalence
of this genotype may be related to enhanced virulence,
transmissibility, and/or specific adaptation to a host population,
isolates with the CS genotype need to be studied carefully.
According to literature reports, the Beijing genotype has
significant associations with drug-resistance and might be
responsible for the spread and emergence of MDR-TB. Studies
in several countries including Vietnam, Germany, Cuba and
America, have confirmed these results. Because of the high
incidence of the Beijing genotype in many regions, some
researchers have proposed that the Beijing genotype may be
correlated with high virulence and easy transmission. In order to
define any association of drug resistance with the Beijing genotype,
we determined the frequency of the Beijing genotype among
bacterial isolates exhibiting different categories of drug resistance.
In this study, comparison between Beijing genotype and non-
Beijing genotype, the resistance to RIF and OFLX was both
significantly higher in Beijing, In agreement with previous reports,
the proportion of MDR-TB was also higher in Beijing genotypes
compared to non-Beijing families. In 2006, Nikolayevskyy et al.
revealed that the Beijing genotype was closely related to RIF and
INH resistance as well as to MDR in the Ukraine [27]. Research
in Central Asia showed similar results, including higher RIF, INH,
SM and MDR resistance in Beijing family [12]. Referred to
OFLX, Duong et al. reported that gyrA mutations were more
common in Beijing type, which resulted in higher levels of OFLX
resistance [28]. In contrast to previous studies [20], we found that
the non-Beijing genotype presented higher SM resistance than
Beijing. Our results are in agreement with studies performed by
Niemann et al. [29] and Tanveer et al. [30], respectively, which
showed that some non-Beijing genotypes represented higher
percentage of SM-resistance. It is obvious that non-Beijing
genotype comprised of a large number of sub-genotypes. Hence,
the conflicting results observed in different studies may be due to
the different distribution of non-Beijing genotypes. While the
association between Beijing genotype and levels of drug resistance
appear to arise from high mutation rates in drug resistance-
associated genes, it was not determined whether virulence and
infectivity of the Beijing family was more critical than other
genotypes. That is because the discriminatory power of spoligo-
typing is not ideal, and the strains selected as the Beijing type may
not represent for Beijing family well.
Some published studies have revealed several families of non-
Beijing genotypes, such as Haarlem family [31] and LAM family
[32], have also shown affinity to drug resistance. Therefore, it is
meaningful to analyze the relationship between spoligotype and
drug-resistant phenotypes in China. After analysis towards the fifth
most popular and new found (CS) types, we can find that ST1, the
main member of Beijing genotype in China, was responsible for
the strong association between the Beijing genotype and resistance
to several drugs as well as with MDR-TB. In this investigation we
also found a high proportion of drug resistance in ST54 genotypes
from the MANU2 family. The level of INH, EMB and SM
resistance for ST54 was even greater than ST1. The MANU2
family has a low prevalence worldwide, so there are few reports on
an association between phenotype and the MANU2 genotype. In
a study from South Africa, 2 isolates were enrolled, one of which
was resistant to RIF, and the other of which was INH resistant. As
this is the first report of a strong association between drug
resistance and the MANU2 family genotype, further confirmatory
research is needed. In addition, the drug resistance of CS type
displayed similar patterns with ST1, which also indicated that CS
type was a member of Beijing family, and might derive from ST1.
This study shows the prevalence of different TB genotypes in
China for the first time, which completes broad pictures on drug
resistance levels and distribution of M. tuberculosis strain types over
China, and Beijing genotype (62.2%) is still the predominant
strains in China, while the percentage of the type is lower than
previous report. The distribution of Beijing family represents that
the proportion of north is significant higher than that of south.
Due to the characters of population mobility in China, the
composition of other spoligotypes also shows distinct features.
Because of the limitation of spoligotyping, future studies are
needed to perform genotyping with more powerful technologies to
consummate the genotype data, such as MIRU-VNTR and
RFLP. Moreover, Beijing family is found to be significantly
associated with RIF and OFLX resistance, as well as with MDR-
TB, and it is essential to carry out a systematic study on
relationship between genotype and phenotype of Beijing genotype.
Materials and Methods
Study population and bacterial strains
A total of 4017 clinical strains of tuberculosis, isolated from the
base-line surveillance of tuberculosis in 2006, were collected from
31 provinces in China excluding Taiwan, Hong Kong and Macao.
The distribution of isolates was shown in Figure 2. The number of
patients enrolled in surveillance was proportionally based on
patient numbers in different provinces. The protocols applied in
this study were approved by the Ethics Committee of the Chinese
Center for Disease Control and Prevention. Patients were able to
access the study if they signed an Informed Consent form. All
strains, stored in Trypticase soy broth with glycerol ay 270uC
freezer, were recovered on Lowenstein-Jensen medium for 4 weeks
at 37uC.
Genotyping and Drug Resistance of TB from China
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Mycobacterium identification and testing of the drug suscepti-
bility of these strains to four first-line anti-TB drugs (isonazid,
rifampin, ethambutol and streptomycin) and two second-line anti-
TB drugs (kanamycin and ofloxacin) were performed as
recommended by WHO/IUATLD [33]. The concentrations of
drugs in media were as following: isonazid 0.2 mg/mL, rifampin
40 mg/mL, ethambutol 2 mg/mL, streptomycin 4 mg/mL, kana-
mycin 30 mg/mL and ofloxacin 2 mg/mL. Strains resistance to
isoniazid and rifampin were defined as MDR-TB. The strains was
declared resistant to the specific drug when the growth rate was
.1% compared to the control. In addition, XDR-TB was defined
as isolates resistant to rifampicin and isoniazid, as well as any
member of the quinolone family and at least one of the following
second-line anti-TB injectable drugs. Media supplied separately
with paranitrobenzoic acid (500 mg/mL) and thiophen-2-carbox-
ylic acid hydrazide (5 mg/mL) was used to perform Mycobacte-
rium species identification. All the drugs were purchased from
Sigma-Aldrich (St. Louis, MO).
Molecular typing methods
Genomic DNA was extracted from freshly cultured bacteria.
Cells were resuspended in 500 mL TE buffer(pH 8. 0), then heated
in 95uC water bath for 1 hour. After centrifugation of cellular
debris, DNA in the supernatent served as PCR template.
Spoligotyping was used to identify the genotype of TB strain in
the DR locus as described previously [10]. A commercially
available kit (Isogen Bioscience BV, Maarssen, The Netherlands)
was used as described by the manufacturer. All chromosomal
DNA was amplified with primers DRa (59-CCGAGAGGG-
GACGGAAAC-39) and DRb (59-GGTTTTGGGTCTGAC-
GAC-39). Then the amplified products were hybridized with the
membrane. After washing with 26SSPE solution (360 mM NaCl,
20 mM NaH2PO4, 2 mM EDTA [pH 7.2]) supplemented with
0.5% SDS, the membrane was hybridized with streptavidin-
peroxidase conjugate. The final image was detected with a
chemiluminescence system, including the ECL detection liquid
(Amersham, Buckinghamshire, United Kingdom) and ECL-
Hyperfilm (Kodak, Rochester, NY). Beijing genotype strains were
defined with the pattern that hybridized to all of the last nine
spacer oligonucleotides (spacers 35 to 43), and Beijing-like
genotype strains were ones that hybridized to only some of the
last nine spacers.
Data analysis
The genotyping were expressed in binary and octal formats in
Microsoft Excel spreadsheets. Drug resistance test results were
arranged in binary formats in Excel. All spoligotype data was
submitted to the international databases MIRU-VNTRplus
(http://www.miru-vntrplus.org) [23] and SpolDB4.0 http://www.
pasteur-guadeloupe.fr:8081/SITVITDemo) [13]. In addition, the
resulting data was analyzed using BioNumerics (Version5. 0,
Applied Maths, Sint-Martens-Latem, Belgium) software. Cluster
Figure 2. Distribution map of M. tuberculosis isolates included in this study. The provinces colored with red represent the northern region
of China including Heilongjiang, Jilin, Liaoning, Inner Mongolia, Hebei, Beijing, Tianjin, Shandong, Henan, Shanxi, Shaanxi, Ningxia, Gansu, Qinghai
and Xinjiang. And the provinces colored with yellow represent the southern region of China including Jiangsu, Anhui, Hunan, Sichuan, Yunnan,
Guizhou, Guangdong, Guangxi, Fujian, Jiangxi, Zhejiang, Hainan, Xizang, Shanghai and Chongqing.
doi:10.1371/journal.pone.0032976.g002
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Bionumerics using the Dice similarity coefficient and UPGMA
coefficient. In addition, statistical analyses between genotype and
phenotype were performed in SPSS 11.5 (SPSS Inc.). Chi-square
and Crosstab analysis were run to identify if the differences between
two statistical datas were significant, and P value less than 0.05, 0.01
and 0.001 were defined as ‘‘significant’’, ‘‘highly significant’’ and
‘‘extremely significant’’ diversity, respectively. The extent of
association was shown as an odds ratio (OR) and 95% confidence
interval (95% C.I.).
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